Skaff Michael C
SEC insider (Form 3/4/5 filer). CIK 0002074003. 10% Owner at Vivos Therapeutics, Inc. (VVOS). 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in GROSSE POINTE, MI.
Companies Skaff Michael C has filed insider reports for
- Vivos Therapeutics, Inc. (VVOS): 10% Owner
Skaff Michael C
CIK: 0002074003
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Vivos Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 30, 2026VVOS
Vivos Therapeutics, Inc.
PurchaseIndirectSeries A Convertible Preferred Stock
859.2K shares at avg. $0.58- - Jun 30, 2026VVOS
Vivos Therapeutics, Inc.
PurchaseIndirectSeries A Convertible Preferred Stock
1.9M shares at avg. $0.58- - Jun 30, 2026VVOS
Vivos Therapeutics, Inc.
PurchaseIndirectCommon Stock Purchase Warrant
2.7M shares at avg. $0.58- - Mar 31, 2026VVOS
Vivos Therapeutics, Inc.
PurchaseIndirect1M shares at avg. $1.34$1.4M - Mar 31, 2026VVOS
Vivos Therapeutics, Inc.
PurchaseIndirect308.8K shares at avg. $1.34$414K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 | VVOS Vivos Therapeutics, Inc. | Purchase Series A Convertible Preferred Stock | 859,166 | $0.58 | - | Indirect |
| Jun 30, 2026 | VVOS Vivos Therapeutics, Inc. | Purchase Series A Convertible Preferred Stock | 1,890,164 | $0.58 | - | Indirect |
| Jun 30, 2026 | VVOS Vivos Therapeutics, Inc. | Purchase Common Stock Purchase Warrant | 2,749,330 | $0.58 | - | Indirect |
| Mar 31, 2026 | VVOS Vivos Therapeutics, Inc. | Purchase | 1,044,777 | $1.34 | $1,400,001 | Indirect |
| Mar 31, 2026 | VVOS Vivos Therapeutics, Inc. | Purchase | 308,848 | $1.34 | $413,856 | Indirect |
1-5 of 5 transactions